Cerebrospinal fluid ubiquitin as a biomarker for neurodegenerative diseases: A systematic review.

Neurosci Appl · 2023 · PMC12244120 · PMID 40655970

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The two additional studies using ELISA also detected increased levels of ubiquitin in AD compared to controls, but either did not reach statistical significance ( Chalbot et al., 2011 ) or no p -value was provided ( Iqbal et al., 2005 ; Chalbot et al., 2011 assessed the discriminative power of CSF ubiquitin between AD patients divided into age groups.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.